SUTENT® (sunitinib)

Drug SUTENT® sunitinib Sutent Overview This is a summary of the European public assessment report (EPAR) for Sutent. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Sutent. How is Sutent used? Treatment with Sutent […]

GLIVEC® (imatinib)

Drug GLIVEC® Pembrolizumab Glivec Overview This is a summary of the European public assessment report (EPAR) for Glivec. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Glivec. How is Glivec used? Glivec treatment should […]

STIVARGA® (regorafenib)

Drug STIVARGA® regorafenib Stivarga Overview This is a summary of the European public assessment report (EPAR) for Stivarga. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Stivarga. For practical information about using Stivarga, […]

LONSURF® (trifluridine / tipiracil)

Drug LONSURF® trifluridine / tipiracil Lonsurf Overview Lonsurf is a medicine used to treat adults with colorectal cancer (cancer of the large bowel) and gastric (stomach) cancer. It is used when the cancer is metastatic (has spread to other parts of the body) in patients who have already been treated with, or who cannot be […]

CYRAMZA® (ramucirumab)

Drug CYRAMZA® ramucirumab Cyramza Overview Cyramza is a cancer medicine used to treat adult patients with: advanced gastric cancer (cancer of the stomach) or cancer of the area where the gullet (oesophagus) enters the stomach (known as gastro-oesophageal junction adenocarcinoma). Cyramza is used in combination with another medicine, paclitaxel, or on its own if the […]

XELODA® (capecitabine)

Drug XELODA® capecitabine Xeloda Overview Xeloda is a cancer medicine that is used to treat: colon (large bowel) cancer. Xeloda is used on its own or with other cancer medicines in patients who have had surgery for stage III or Dukes’ stage C colon cancer; metastatic colorectal cancer (cancer of the large bowel that has […]

HERCEPTIN® (trastuzumab)

Drug HERCEPTIN® Trastuzumab Herceptin Overview This is a summary of the European public assessment report (EPAR) for Herceptin. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Herceptin. How is Herceptin used? Herceptin treatment should […]

LUTATHERA® (lutetium (177Lu) oxodotreotide)

Drug LUTATHERA® lutetium (177Lu) oxodotreotide Lutathera Overview This is a summary of the European public assessment report (EPAR) for Lutathera. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Lutathera. For practical information about […]